Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Ocuphire Pharma, Inc. (OCUP)

1.89   -0.03 (-1.56%) 07-02 19:43
Open: 1.85 Pre. Close: 1.92
High: 1.92 Low: 1.85
Volume: 124,354 Market Cap: 37(M)
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induced mydriasis, as well as that has completed Phase 2 VEGA-1 trial for presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.92 - 1.93 1.93 - 1.94
Low: 1.82 - 1.83 1.83 - 1.85
Close: 1.87 - 1.89 1.89 - 1.91

Technical analysis

as of: 2022-07-01 4:24:08 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.38     One year: 2.56
Support: Support1: 1.77    Support2: 1.48
Resistance: Resistance1: 2.03    Resistance2: 2.2
Pivot: 1.93
Moving Average: MA(5): 1.93     MA(20): 1.97
MA(100): 2.69     MA(250): 3.54
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 32.7     %D(3): 36
RSI: RSI(14): 41.7
52-week: High: 5.5  Low: 1.77
Average Vol(K): 3-Month: 136 (K)  10-Days: 113 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ OCUP ] has closed above bottom band by 33.4%. Bollinger Bands are 64.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 30 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 24 Jun 2022
We're Keeping An Eye On Ocuphire Pharma's (NASDAQ:OCUP) Cash Burn Rate - Simply Wall St

Wed, 08 Jun 2022
Ocuphire to Present New Interim Masked Safety Data for Oral APX3330 in Diabetics at Annual Macula Society Meeting - Yahoo Finance

Thu, 19 May 2022
Ocuphire Announces Positive Topline Results from LYNX-1 Phase 3 Trial Evaluating Nyxol® Eye Drops for Night Vision Disturbances - Yahoo Finance

Wed, 06 Apr 2022
Ocuphire Pharma to Present at Wet AMD & DME Drug Development Summit in Boston, MA - GlobeNewswire

Wed, 30 Mar 2022
Here Are 3 Stocks I'm Trading as the Market Action Is Mixed - RealMoney

Tue, 29 Mar 2022
Ocuphire Pharma Inc (OCUP) Stock Decreases -9.42% This Week; Should You Buy? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. -12 (M)
Shares Float 0 (M)
% Held by Insiders 1.73e+007 (%)
% Held by Institutions 1.646e+007 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -1.458e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -5.63
Profit Margin (%) 0
Operating Margin (%) -3
Return on Assets (ttm) 854.8
Return on Equity (ttm) -64.9
Qtrly Rev. Growth 295.1
Gross Profit (p.s.) 0
Sales Per Share 0.03
EBITDA (p.s.) -1.18
Qtrly Earnings Growth -2.27e+007
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value -0.34
Price to Sales 60.48
Price to Cash Flow 0

Stock Dividends

Dividend 298140
Forward Dividend 293600
Dividend Yield 15774600%
Dividend Pay Date 2020-11-05
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.